GOAL STATEMENT

This CME conference aims to deliver a comprehensive educational update that highlights the most clinically relevant advances in chronic liver and gastrointestinal (GI) diseases. The 1.5-day conference will have a strong focus on viral hepatitis, non-alcoholic steatohepatitis, primary biliary cirrhosis, complications of cirrhosis, including hepatic encephalopahy and thrombocytopenia, hepatocellular carcinoma, and irritable bowel syndrome.

​

TARGET AUDIENCE

Gastroenterologists, hepatologists, internists, family practitioners, surgeons, physician assistants, nurse practitioners, fellows/residents in training, registered nurses, and other healthcare professionals with an interest in GI and liver diseases.

 

STATEMENT OF NEED / PROGRAM OVERVIEW

Digestive diseases include a wide spectrum of disorders affecting the oropharynx and alimentary canal, the liver and biliary system, and the pancreas. Chronic GI disorders are common in the US and the prevalence is increasing. Considerable overlap can be found in the symptoms of serious GI diseases and the symptoms of benign or functional GI diseases. Noninvasive diagnostic tests, sensible clinical evaluation plans, and a clear understanding of disease progression will enhance patient assessment/management and identify the right patients for referral to GI specialists. For patients with a confirmed diagnosis of a chronic GI disorder, advances in the understanding of the clinical impact of evolving treatment options offer new choices for managing these conditions.

 

The conference format will consist of lectures, Q&A/panel discussions, and parallel breakout sessions for in-depth discussions of high-interest topics.

 

CME LEARNING OBJECTIVES

Upon completion of this conference, participants should be better able to:

• Describe evolving patient management and treatment strategies for CLD and GI disorders

• Integrate significant advances in therapeutic and diagnostic modalities into clinical practice

• Apply the latest clinical research, including future therapies and their role in the context of the current clinical paradigm

 

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower, the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute (TLI). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

 

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

ANCC ACCREDITATION 

The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

 

A maximum of 11.0 contact hours may be earned for successful completion of this activity.